Sage Integrative Health • Alexander Shulgin Research Institute • Berkeley Center for the Science of Psychedelics (BCSP)
Operations Manager • Psychiatry position • Development Director
Sage Integrative Health • Alexander Shulgin Research Institute • Berkeley Center for the Science of Psychedelics (BCSP)
Operations Manager • Psychiatry position • Development Director
ATAI Life Sciences • Introspect • Psychedelic Society Berlin • PsychonautWiki • Viridia Life Science • Charite University, Berlin, Germany • MIND Foundation • Empath Bio • OVID Health Systems • German Federal Ministry of Education and Research
ATAI Life Sciences AG • Masawa Management • Berggruen Holdings
Florian Brand • Simon Seibold • Joshua Haynes
Internship - Business Operations • Business Operations & Strategy Manager (m/w/d) • Business Operations Intern • Business Associate • Working Student - Business Operations • Head of Investment (m/w/d) • Business Operations & Strategy Manager (m/w/d) • VP Human Resources/People • VP of Investment
Ketamine-Induced Brain Changes and Their Modulation by Lamotrigine • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia. • Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects • A Study to Assess Electrophysiology, Safety, Tolerability, and Pharmacokinetics of Multiple Doses of SAGE-718 Using Ketamine Challenge in Healthy Subjects • A Study to Assess the Electrophysiology, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Response Using Magnetic Resonance Imaging of SAGE-718 Using a Ketamine Challenge in Healthy Subjects • Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.
Psychedelic Society Switzerland • Schweizerischer Nationalfonds • University of Bern
Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
Besançon, Bourgogne-Franche-Comté, France
The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression
National Institute on Drug Abuse (NIDA) • National Institute of Neurological Disorders and Stroke (NINDS) • National Institutes of Health Clinical Center (CC) • National Institute on Minority Health and Health Disparities (NIMHD) • National Institutes of Health (NIH) • National Institute of Mental Health (NIMH) • National Cancer Institute (NCI) • National Institute of General Medical Sciences (NIGMS) • National Institute of Nursing Research (NINR) • Mid-Atlantic Epilepsy and Sleep Center, LLC • National Center for Research Resources (NCRR) • National Institute on Deafness and Other Communication Disorders (NIDCD) • National Institute on Aging (NIA) • Walter Reed National Military Medical Center
Evaluating Ketamine and Psychological Sequelae • Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain • A Proof-of-Concept Trial on the Effect of Ketamine on Fatigue • Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder • Mechanism of Action Underlying Ketamine s Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression • Effect of Ketamine on Fatigue Following Cancer Therapy • Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus • Rapid Antidepressant Effects of Ketamine in Major Depression • Neurobiology of Suicide
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Beverly Hills, California, USA
Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia
Biberist, Solothurn, Switzerland
Study of 3,4-Methylenedioxymethamphetamine-assisted Psychotherapy in People With Posttraumatic Stress Disorder
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Multiple-dose,Double-blind,Placebo-controlled Study of Sodium Oxybate in Patients With Essential Tremor • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.
University of Alabama at Birmingham
Psilocybin-facilitated Treatment for Cocaine Use • Intranasal Versus Intravenous Ketamine for Procedural Sedation in Children With Non-operative Fractures • A Study to Evaluate Ketamine for the Treatment of Rett Syndrome • Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea • Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus • A Study of Ketamine in Patients With Treatment-resistant Depression • miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome • Treatment of Suicidal Ideation With Intravenous Ketamine Infusion • Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic Surgery • Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression • Sequential Therapy for the Treatment of Severe Bipolar Depression. • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.
Birmingham, England, United Kingdom
Psychedelic Society of Birmingham
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Neuma Coaching
Virginia Polytechnic Institute and State University
Indiana University
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
HealthPartners Institute
Blumenau, Santa Catarina, Brazil
Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression
Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain
Bobigny, Île-de-France, France
Ketamine Versus Etomidate During Rapid Sequence Intubation: Consequences on Hospital Morbidity
Böblingen, Baden-Württemberg, Germany
Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.
Psybio Therapeutics • Florida Atlantic University
Robert Streisfeld • Scott Fisher
Bologna, Emilia-Romagna, Italy
Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi • University of Bologna
Comparative Study of Gamma-hydroxy Butyrate Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrome • Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
Bolton, England, United Kingdom
Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.
Bonn, North Rhine-Westphalia, Germany
University of Bonn
Effects of Ketamine on Eye Movements, Perception and Brain Function
Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.
Bordeaux, Nouvelle-Aquitaine, France
University Hospital, Bordeaux • Institut Bergonié
Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia • Administration of Ketamine to Prevent the Post-operative Pain • Polyamine-free Diet to Prevent Post Surgery Hyperalgesia
Eleos • Center for the Neuroscience of Psychedelics • Adelia Therapeutics • Vicente Sederberg • Brigham and Women's Hospital • Boston University • Harvard Medical School • Boston Children's Hospital • Invicro • Massachusetts General Hospital • Beth Israel Deaconess Medical Center • Beth Israel Medical Center • Massachusetts Eye and Ear Infirmary • Tufts Medical Center • Concert Pharmaceuticals • Psy Therapeutics • Hyka Therapeutics
MAZAKALI • Psilos Group
Bob Peatman • Stephen Krupa • Joseph Tucker • Doug Drysdale • Adam Von Reyn
Program Manager - Center for Neuroscience of Psychedelics • Director Quality Assurance Regulatory Affairs • Director Clinical Operations • Director, Clinical Operations • Formulation/Analytical Chemist • Director, Quality Assurance
A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD • EEG Studies of Ketamine General Anesthesia • Ketamine for Depression: An MRI Study • Physiological and Cognitive Biomarkers for Ketamine's Antidepressant Effects • A Study to Evaluate Ketamine for the Treatment of Rett Syndrome • Ketamine Infusion for Treatment-resistant Major Depressive Disorder • Immunomodulatory Properties of Ketamine in Sepsis • A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) • Prevention of Post Mastectomy With Intraoperative Ketamine • The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures • Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder • Effect of Ketamine on Opioid-Induced Hyperalgesia • Efficacy Study of Ketamine for Postoperative Pain in Opioid Dependent Patients • Ketamine for Major Depressive Disorder • The Impact of Ketamine on the Reward Circuitry of Suicidal Patients • Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD) • Remifentanil Plus Ketamine for Dynamic Flexible Bronchoscopy • Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder • Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients • N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression • EEG Studies of Sevoflurane-Induced General Anesthesia • Avoiding Neuromuscular Blockers to Reduce Complications • Prevention of Phantom Limb Pain After Transtibial Amputation • The PATHFINDER Study: A Feasibility Trial • EEG Monitoring in the Emergency Department • Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor • The Effect of Sodium Oxybate on Sleep Architecture • Evaluation of the Efficacy of Sodium Oxybate (Xyrem®) in Treatment of Post-traumatic Narcolepsy and Post-traumatic Hypersomnia
Alder Biopharmaceuticals, Inc.
Naropa University • Medicinal Mindfulness • The Awake Network • Magic Agency • Gaia • Psychedelic Club • Integrative Psychiatry Institute
Larry Norder
Study Coordinator
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP1) • A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD • Psychological Effects of Methylenedioxymethamphetamine (MDMA) When Administered to Healthy Volunteers • Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • An Open Label Study of FT218 in Subjects With Narcolepsy • A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
Boulogne-Billancourt, Île-de-France, France
Hospital Ambroise Paré Paris
Bourgogne-Franche-Comté, France
Centre Hospitalier Universitaire de Besancon
Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy • Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia • Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia.
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Slovak psychedelic society - SAPAS
Centro Medico Campinas • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Breda, North Brabant, Netherlands
Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. • A Safety and Efficacy Study of Xyrem® (Sodium Oxybate) to Treat Fibromyalgia.
Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
Brentford, England, United Kingdom
GlaxoSmithKline
Foundations Recovery Network • American College of Neuropsychopharmacology
KWCG Psychedelic Society
Brisbane, Queensland, Australia
Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
Bristol, England, United Kingdom
The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression • Bristol Imperial MDMA in Alcoholism Study
Medcan Biotechnologies • Optimi Health • HealthTech Connex • Albert Labs
Brno University Hospital
Intranasal Ketamine for Suicidal Ideation in Veterans • Intranasal Ketamine For Pain Control In Patients With Sickle Cell Disease And Vaso-occlusive Episode (VOE) In The PED • A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD) • Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy • An Open Label Study of FT218 in Subjects With Narcolepsy • A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy